| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.393 | 14.532 | - | 19.369 | 53.586 | 60.394 | 70.498 | 57.790 | 50.732 | 96.406 |
| Total Income - EUR | 14.393 | 14.532 | - | 19.369 | 53.586 | 62.164 | 70.498 | 57.790 | 50.732 | 130.201 |
| Total Expenses - EUR | 5.379 | 6.262 | - | 9.342 | 36.801 | 42.921 | 44.967 | 31.991 | 54.857 | 144.487 |
| Gross Profit/Loss - EUR | 9.014 | 8.270 | - | 10.027 | 16.785 | 19.243 | 25.531 | 25.799 | -4.125 | -14.286 |
| Net Profit/Loss - EUR | 8.582 | 7.980 | - | 9.833 | 16.249 | 18.684 | 24.826 | 25.221 | -4.632 | -14.286 |
| Employees | 2 | 0 | - | 1 | 2 | 3 | 3 | 2 | 2 | 4 |
Check the financial reports for the company - Vernesmedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 298.287 | 307.556 |
| Current Assets | 18.176 | 8.033 | - | 26.358 | 49.431 | 23.543 | 28.002 | 27.624 | 63.886 | 11.600 |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.379 |
| Receivables | 0 | 0 | - | 1.485 | 40.039 | 22.547 | 1.226 | 19.518 | 59.602 | 5.035 |
| Cash | 18.176 | 8.033 | - | 24.873 | 9.393 | 996 | 26.776 | 8.105 | 4.284 | 5.186 |
| Shareholders Funds | 17.796 | 8.033 | - | 25.864 | 41.612 | 19.877 | 24.875 | 25.270 | 1.169 | -12.996 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 381 | 0 | - | 494 | 7.819 | 3.666 | 3.127 | 2.354 | 166.744 | 172.224 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 194.260 | 159.929 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Vernesmedica Srl